PDF
ePub
Citation
Print
Abstract
Mycoplasma pneumoniae is increasingly recognized as a common and an important pathogen in community-acquired respiratory tract infections (RTIs) and pneumonia, particularly in school-age children and young adults. To determine the incidence and antibiotic susceptibility of M. pneumoniae at the main hospitals in Riyadh, Saudi Arabia, we studied 552 respiratory samples from patients diagnosed with different clinical diagnosis. The isolation, identification, enumeration and antibiotic resistance test for M. pneumoniae were performed using Pneumofast kit. There were 194 patients (35.1%) with current M. pneumoniae infection, mostly among younger age groups, with pneumonia the most common underlying clinical condition. All tested isolates were susceptible to four antibiotics included in the Pneumofast kit, doxycycline, minocycline, ciprofloxacine and erythromycin. The findings suggest that M. pneumonia infection in Saudi Arabia is more common among younger age groups, and pneumonia is the most common underlying clinical condition among patients with M. pneumoniae infection, that cannot be distinguished from other respiratory infections on the basis of clinical and radiographic diagnosis alone.
REFERENCES
1). Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998. 62:1094–156.
2). Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther. 2008. 6:509–21.
3). Waites KB., Talkington DE. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004. 17:697–728.
4). Chiang WC., Teoh OH., Chong CY., Goh A., Tang JP., Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology. 2007. 12:254–61.
5). Al Rashed A. Role of Mycoplasma pneumoniae in acute respiratory-tract infections in Saudi paediatric patients. Ann Trop Med Parasitol. 1998. 92:595–601.
6). Kurashi NY., Al-Hamdan A., Ibrahim EM., Al-Idrissi HY., Al-Bayari TH. Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax. 1992. 47:115–8.
7). Moule JH., Caul EO., Wreghitt TG. The specific IgM response to Mycoplasma pneumoniae infection: interpretation and application to early diagnosis. Epidemiol Infect. 1987. 99:685–92.
8). Lind K., Benzon MW., Jensen JS., Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946~1995. Eur J Epidemiol. 1997. 13:581–6.
9). Gray GC., Rodier GR., Matras-Maslin VC., Honein MA., Ismail EA., Botros BA, et al. Serologic evidence of respiratory and rickettsial infections among Somali refugees. Am J Trop Med Hyg. 1995. 52:349–53.
10). Kleemola SR., Karjalainen JE., Räty RK. Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test. J Infect Dis. 1990. 162:70–5.
11). Chay OM., Hiew J., Tan CK., Foo AL., Lim KW., Cheng HK. Etiology of acute severe lower respiratory tract infection in hospital-based patients. Southeast Asian J Trop Med Public Health. 1992. 23:293–6.
12). Foy HM. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis. 1979. 139:681–7.
13). Lieberman D., Porath A. Seasonal variation in community-acquired pneumonia. Eur Respir J. 1996. 9:2630–4.
14). Ghosh K., Clements GB. Surveillance of Mycoplasma pneumoniae infections in Scotland 1986~1991. J Infect. 1992. 25:221–7.
15). Saikku P., Ruutu P., Leinonen M., Kleemola M., Paladin F., Tupsi TE. Mycoplasma pneumoniae and Chlamydia trachomatis in acute lower respiratory infections in Filipino children. Am J Trop Med Hyg. 1993. 49:88–92.
16). Sung RY., Cheng AF., Chan RC., Tam JS., Oppenheimer SJ. Epidemiology and etiology of pneumonia in children in Hong Kong. Clin Infect Dis. 1993. 17:894–6.
17). Vikerfors T., Brodin G., Grandien M., Hirschberg L., Krook A., Pettersson CA. Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: a clinical evaluation. Scand J Infect Dis. 1988. 20:601–10.
18). Lind K., Bentzon MW. Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark. Epidemiol Infect. 1991. 107:189–99.
19). Dorigo-Zetsma JW., Zaat SA., Wertheim-van Dillen PM., Spanjaard L., Rijintjes J., van Waveren G, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol. 1999. 37:14–7.
20). Kenny GE., Cartwright FD. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. Antimicrob Agents Chemother. 1991. 35:587–9.
21). Waites KB., Duffy LB., Schmid T., Crabb D., Pate MS., Cassell GH. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 1991. 35:1181–5.
Table 1.
Baseline characteristics of 552 patients with respiratory symptoms tested for M. Pneumoniae culture
Table 2.
The incidence of culture-proven M. pneumonia infection in 194 Patients
XML Download